• Gerald Appel, MD, Dana V. Rizk, MD - Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies

  • 2025/03/05
  • 再生時間: 42 分
  • ポッドキャスト

Gerald Appel, MD, Dana V. Rizk, MD - Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies

  • サマリー

  • This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XJK865. CME credit will be available until February 25, 2026.

    Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies

    Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.

    Support
    This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示

あらすじ・解説

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XJK865. CME credit will be available until February 25, 2026.

Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapies

Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.

Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Disclosure information is available at the beginning of the video presentation.

Gerald Appel, MD, Dana V. Rizk, MD - Advancements in IgA Nephropathy: Discovering the Potential of Complement Pathway Therapiesに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。